While Type II endometrial cancers tend to metastasize and are hormone-independent, Type I endometrial cancers are generally considered endocrine-dependent and commonly have mutations in PTEN, members of the PI3K/AKT pathway, and KRAS [26,27,28,29]. The gene discussed is KRAS; the disease is endometrial cancer.